Holger Weis

Chair of the Board of Directors, President of Weis Advisors, Inc.

Therapeutic Areas

Drug	Indication	Phase
Oral Non-Incretin Small Molecule	Obesity & Metabolic Disorders	Pre-clinical
TCR-T Cell Therapies (Platform)	Cancer (Solid Tumors)	Discovery/Platform